495 results on '"Ehinger, Mats"'
Search Results
2. Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity
3. Immunologic Control of Disseminated Aichi Virus Infection in X-Linked Agammaglobulinemia by Transplantation of TcRαβ-Depleted Haploidentical Hematopoietic Cells
4. Endobronchial ultrasound‐guided transbronchial fine needle aspiration of mediastinal lymphadenopathy: Diagnostic performance and clinical implications of the World Health Organization reporting system
5. Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia
6. CXCR4 Signaling Has a CXCL12-Independent Essential Role in Murine MLL-AF9-Driven Acute Myeloid Leukemia
7. Lymph Nodes
8. Spleen
9. Immunohistochemistry and Flow Cytometry in Bone Marrow Haematopathology
10. Molecular Diagnostics in Bone Marrow Haematopathology
11. Signaling via Smad2 and Smad3 is dispensable for adult murine hematopoietic stem cell function in vivo
12. Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years
13. Digital Examination of LYmph node CYtopathology Using the Sydney system (DELYCYUS): An international, multi‐institutional study
14. Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma
15. Lymph Nodes
16. Spleen
17. Lentiviral Gene Therapy Using Cellular Promoters Cures Type 1 Gaucher Disease in Mice
18. miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator
19. Lymph Nodes
20. Spleen
21. Digital Examination of LYmph node CYtopathology Using the Sydney system (DELYCYUS). An international, multi-institutional study
22. Long-Term Follow-up of Clinical Outcome Determinants and Correlative Biological Features from the Nordic NLG-T-01 Trial
23. Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma
24. Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemia
25. CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization
26. Murine Models of Acute Neuronopathic Gaucher Disease
27. Receptors for hematopoietic regulatory cytokines: Overview of structure and function
28. Unsupervised cluster analysis and subset characterization of abnormal erythropoiesis using the bioinformatic Flow‐Self Organizing Maps algorithm
29. Effective Cell and Gene Therapy in a Murine Model of Gaucher Disease
30. Patient‐tailored analysis of minimal residual disease in acute myeloid leukemia using next‐generation sequencing
31. Modeling the human 8p11-myeloproliferative syndrome in immunodeficient mice
32. Canonical BMP signaling is dispensable for hematopoietic stem cell function in both adult and fetal liver hematopoiesis, but essential to preserve colon architecture
33. Low-dose busulphan conditioning and neonatal stem cell transplantation preserves vision and restores hematopoiesis in severe murine osteopetrosis
34. Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group
35. SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma – a Nordic Lymphoma Group study
36. Comparison of RNA‐ and DNA‐based methods for measurable residual disease analysis in NPM1 ‐mutated acute myeloid leukemia
37. Letter to the Editor: Fine‐needle aspiration cytology and core‐needle biopsy in the diagnosis of lymphadenopathies: Words of endorsement
38. Is there an impact of measurable residual disease as assessed by multiparameter flow cytometry on survival of AML patients treated in clinical practice? : A population-based study
39. Hematopoietic stem cell–targeted neonatal gene therapy reverses lethally progressive osteopetrosis in oc/oc mice
40. HOXA10 is a critical regulator for hematopoietic stem cells and erythroid/megakaryocyte development
41. Spleen
42. Lymph Nodes
43. Mutational spectrum of de novo NPM1-mutated acute myeloid leukemia patients older than 75 years
44. Is there an impact of measurable residual disease as assessed by multiparameter flow cytometry on survival of AML patients treated in clinical practice? A population-based study
45. World Health Organization-defined classification of myeloproliferative neoplasms: Morphological reproducibility and clinical correlations—The Danish experience
46. Neonatal hematopoietic stem cell transplantation cures oc/oc mice from osteopetrosis
47. c-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells
48. Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur
49. Definition of Erythroid Differentiation Subsets in Normal Human Bone Marrow Using FlowSOM Unsupervised Cluster Analysis of Flow Cytometry Data
50. DNA-Based Methods for Measurable Residual Disease Detection in NPM1-Mutated Acute Myeloid Leukemia; Establishment of Cut-Offs for qPCR, Digital Droplet PCR and Targeted Deep Sequencing
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.